Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Ruboxistaurin | 169939-94-0 | 99.5% | 468.55 g/mol | C28H28N4O3 | 100 MG
SDP

Catalog No. 5000248839
Encompass_Preferred

Ruboxistaurin is a selective, orally active protein kinase C beta (PKCβ) inhibitor for preclinical research into PKCβ-related signaling and diabetic vascular complications. It is provided as a solid and as a DMSO solution, and is characterized by defined physicochemical properties and high purity to support reproducible experimental work.

  • Selective PKCβ inhibition for targeted signaling studies.
  • High purity (99.5%) supporting reliable experimental results.
  • Well-characterized molecular properties (C28H28N4O3; 468.55 g/mol).
  • Available in multiple formats and pack sizes for flexible experimental needs.
  • CAS registry linkage for unambiguous compound identification.

Catalog No. 50-002-48839 Supplier Medchemexpress LLC Supplier No. HY10195100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Ruboxistaurin is a selective, orally active protein kinase C beta (PKCβ) inhibitor for preclinical research into PKCβ-related signaling and diabetic vascular complications. It is provided as a solid and as a DMSO solution, and is characterized by defined physicochemical properties and high purity to support reproducible experimental work.

  • Selective PKCβ inhibition for targeted signaling studies.
  • High purity (99.5%) supporting reliable experimental results.
  • Well-characterized molecular properties (C28H28N4O3; 468.55 g/mol).
  • Available in multiple formats and pack sizes for flexible experimental needs.
  • CAS registry linkage for unambiguous compound identification.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.